This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Email citation

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 2005 May;28(5):1240-4.

doi: 10.2337/diacare.28.5.1240.

The use of U-500 in patients with extreme insulin resistance

Elaine Cochran¹, Carla Musso, Phillip Gorden

Affiliations

Affiliation

¹ Clinical Endocrinology Branch, National Institute of Diabetes and Digestive and Kidney Diseases/NIH, 9000 Rockville Pike, Bldg. 10, CRC 6-5940, Bethesda, MD 20892, USA. elainec@intra.niddk.nih.gov

PMID: 15855601
DOI: 10.2337/diacare.28.5.1240

Review

The use of U-500 in patients with extreme insulin resistance

Elaine Cochran et al. Diabetes Care. 2005 May.

. 2005 May;28(5):1240-4.

doi: 10.2337/diacare.28.5.1240.

Authors

Elaine Cochran¹, Carla Musso, Phillip Gorden

Affiliation

¹ Clinical Endocrinology Branch, National Institute of Diabetes and Digestive and Kidney Diseases/NIH, 9000 Rockville Pike, Bldg. 10, CRC 6-5940, Bethesda, MD 20892, USA. elainec@intra.niddk.nih.gov

PMID: 15855601
DOI: 10.2337/diacare.28.5.1240

Erratum in

Diabetes Care. 2007 Apr;30(4):1035

No abstract available

PubMed Disclaimer

Comment in

Use of U-500 regular insulin in type 2 diabetes.
Wafa WS, Khan MI. Wafa WS, et al. Diabetes Care. 2006 Sep;29(9):2175-6. doi: 10.2337/dc06-1148. Diabetes Care. 2006. PMID: 16936172 No abstract available.

Similar articles

Insulin U-500 in severe insulin resistance in type 2 diabetes mellitus.
Crasto W, Jarvis J, Hackett E, Nayyar V, McNally PG, Davies MJ, Lawrence IG. Crasto W, et al. Postgrad Med J. 2009 Apr;85(1002):219-22. doi: 10.1136/pgmj.2008.073379. Postgrad Med J. 2009. PMID: 19417173 Review.
Whither inhaled insulin?
Young B. Young B. Nat Clin Pract Endocrinol Metab. 2006 Aug;2(8):413. doi: 10.1038/ncpendmet0264. Nat Clin Pract Endocrinol Metab. 2006. PMID: 16932324 No abstract available.
[The first inhalational insulin. Which patients really profit from it? (interview by Dr. D. Einecke)].
Schumm-Draeger PM. Schumm-Draeger PM. MMW Fortschr Med. 2007 Jan;149(1-2):16-7. MMW Fortschr Med. 2007. PMID: 17632858 German. No abstract available.
Insulin: standard therapy following oral hypoglycaemic failure in type 2 diabetes?
English P. English P. Br J Hosp Med (Lond). 2013 Apr;74(4):192-7. doi: 10.12968/hmed.2013.74.4.192. Br J Hosp Med (Lond). 2013. PMID: 23571388 No abstract available.
Intensive insulin for type 2 diabetes: the risk of causing harm.
Nolan CJ, Ruderman NB, Prentki M. Nolan CJ, et al. Lancet Diabetes Endocrinol. 2013 Sep;1(1):9-10. doi: 10.1016/S2213-8587(13)70027-5. Epub 2013 Jun 13. Lancet Diabetes Endocrinol. 2013. PMID: 24622256 Review. No abstract available.

See all similar articles

Cited by

Searching for the Culprit: When Diabetic Ketoacidosis Presents With Insulin Autoantibodies.
Garcia-Avila S, Samuel A, Farooqi I, Manickam R, Ismail M, Khaddash SI, Gibiezaite S. Garcia-Avila S, et al. AACE Clin Case Rep. 2020 Dec 28;7(2):158-162. doi: 10.1016/j.aace.2020.12.004. eCollection 2021 Mar-Apr. AACE Clin Case Rep. 2020. PMID: 34095477 Free PMC article.
U-500 regular insulin: clinical experience and pharmacokinetics in obese, severely insulin-resistant type 2 diabetic patients.
Davidson MB, Navar MD, Echeverry D, Duran P. Davidson MB, et al. Diabetes Care. 2010 Feb;33(2):281-3. doi: 10.2337/dc09-1490. Epub 2009 Nov 12. Diabetes Care. 2010. PMID: 19910500 Free PMC article.
A Low-Carbohydrate Diet Realizes Medication Withdrawal: A Possible Opportunity for Effective Glycemic Control.
Han Y, Cheng B, Guo Y, Wang Q, Yang N, Lin P. Han Y, et al. Front Endocrinol (Lausanne). 2021 Dec 14;12:779636. doi: 10.3389/fendo.2021.779636. eCollection 2021. Front Endocrinol (Lausanne). 2021. PMID: 34970224 Free PMC article. Clinical Trial.
Application of PK/PD modeling and simulation to dosing regimen optimization of high-dose human regular U-500 insulin.
de la Peña A, Ma X, Reddy S, Ovalle F, Bergenstal RM, Jackson JA. de la Peña A, et al. J Diabetes Sci Technol. 2014 Jul;8(4):821-9. doi: 10.1177/1932296814532326. Epub 2014 May 12. J Diabetes Sci Technol. 2014. PMID: 24876428 Free PMC article. Clinical Trial.
Mild Caloric Restriction Decreases Insulin Requirements in Patients With Type 2 Diabetes and Severe Insulin Resistance.
Meehan CA, Cochran E, Mattingly M, Gorden P, Brown RJ. Meehan CA, et al. Medicine (Baltimore). 2015 Jul;94(30):e1160. doi: 10.1097/MD.0000000000001160. Medicine (Baltimore). 2015. PMID: 26222846 Free PMC article. Clinical Trial.

See all "Cited by" articles

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Silverchair Information Systems
Other Literature Sources
- The Lens - Patent Citations Database
Medical
- MedlinePlus Health Information